# Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

> **NCT06199934** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 19853610 (actual)

## Conditions studied

- SARS-CoV-2
- COVID-19 Vaccines

## Interventions

- **BIOLOGICAL:** Vaccination

## Key facts

- **NCT ID:** NCT06199934
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-11
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 19853610 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06199934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06199934, "Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06199934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*